Xylorin-P Nasal Drops contain Xylometazoline 0.05% w/v, a topical nasal decongestant indicated for the relief of nasal congestion associated with conditions such as allergic rhinitis, sinusitis, and the common cold. Xylometazoline acts as a selective alpha-adrenergic receptor agonist, producing vasoconstriction of the nasal mucosal blood vessels, thereby reducing mucosal edema and facilitating improved nasal airflow. The onset of action is typically rapid, providing symptomatic relief within minutes, with effects lasting up to 10-12 hours. Xylorin-P Nasal Drops are intended for intranasal administration and should be used strictly as directed to avoid potential adverse effects such as rebound congestion or mucosal irritation. It is contraindicated in patients with hypersensitivity to xylometazoline or any of the excipients. Caution is advised in patients with hypertension, cardiovascular disorders, hyperthyroidism, or diabetes mellitus. Prolonged use beyond 3 to 5 consecutive days is not recommended to prevent rhinitis medicamentosa. Common adverse reactions may include nasal dryness, burning sensation, or sneezing. Patients should avoid concurrent use with other sympathomimetic agents. Xylorin-P Nasal Drops provide effective, short-term relief of nasal congestion, improving patient comfort and respiratory function during upper respiratory tract illnesses.